PEPG Q1 2024 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena

PEPGPepGen Inc.

$435M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$376,000

Operating Income

-$20M

Net Income

-$18M

EPS (Diluted)

$-0.63

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$207M

Total Liabilities

$28M

Stockholders' Equity

$179M

Cash & Equivalents

$134M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$376,000	$0	—
Operating Income	-$20M	-$18M	-9.8%
Net Income	-$18M	-$16M	-10.4%